Your browser doesn't support javascript.
loading
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.
Field, Kathryn M; King, Madeleine T; Simes, John; Espinoza, David; Barnes, Elizabeth H; Sawkins, Kate; Rosenthal, Mark A; Cher, Lawrence; Hovey, Elizabeth; Wheeler, Helen; Nowak, Anna K.
Afiliación
  • Field KM; Royal Melbourne Hospital, Parkville, VIC, 3050, Australia. kathryn.field@mh.org.au.
  • King MT; Department of Medicine, University of Melbourne, Parkville, VIC, 3050, Australia. kathryn.field@mh.org.au.
  • Simes J; Psycho-oncology Co-operative Research Group (PoCoG), School of Psychology and Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Espinoza D; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Barnes EH; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Sawkins K; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Rosenthal MA; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Cher L; Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Hovey E; Department of Medicine, University of Melbourne, Parkville, VIC, 3050, Australia.
  • Wheeler H; Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
  • Nowak AK; Prince of Wales Hospital, Barker Street, Randwick, NSW, 2031, Australia.
J Neurooncol ; 133(3): 623-631, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28534153

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carboplatino / Glioblastoma / Bevacizumab / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carboplatino / Glioblastoma / Bevacizumab / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos